Headline
The latest stories from AHA Today.
Rep. Doris Matsui (D-CA) today introduced an AHA-supported bill that would make changes to the 340B drug savings program, including overturning last year’s significant Medicare payment reduction for many hospitals in the program and adding program integrity requirements for drug manufacturers…
The Senate Health, Education, Labor & Pensions Committee today held a hearing examining the administration’s blueprint to lower prescription drug prices.
The Center for Disease Control and Prevention’s National Center for Health Statistics has released the first ICD-10-CM codes for classifying human trafficking abuse.
The Centers for Medicare & Medicaid Services yesterday released a “roadmap” outlining its efforts to combat the opioid epidemic.
The American Medical Association today adopted a policy declaring drug shortages an urgent public health crisis.
The House of Representatives this week is expected to vote on more than 30 bills to address the opioid crisis, with more votes on additional opioid-related bills expected the week of June 18.
The Centers for Medicare & Medicaid Services today issued guidance on designing state approaches to covering treatment services for Medicaid-eligible infants with neonatal abstinence syndrome.
The Centers for Disease Control and Prevention is investigating hepatitis A outbreaks in multiple states among people reporting drug use and/or homelessness and their contacts.
The U.S. District Court for the Northern District of Mississippi has entered a consent decree prohibiting Delta Pharma from manufacturing or distributing compounded drugs until they comply with the Federal Food, Drug, and Cosmetic Act and FDA regulations.
The Maine health commissioner has appealed a court order requiring the state to submit to the Centers for Medicare & Medicaid Services a state plan amendment ensuring Medicaid eligibility for qualified low-income residents.